Uterine fibroids are the most common benign tumors of the female genitalia and one of the main causes of hysterectomy, often occurring between the ages of 30 and 50. It is formed by abnormal proliferation of smooth muscle of the uterus, and about 20% of women of childbearing age suffer from this disease. Uterine fibroids can be classified according to their growth sites: submucosal fibroids, interstitial fibroids, subplasma fibroids, cervical fibroids and fibroids in the broad ligament. The cause of uterine fibroids is still unclear, but may be related to long-term excessive estrogen stimulation. Common symptoms: abnormal menstruation, increased leucorrhea, abdominal mass, abdominal pain, back pain and lower abdominal chasing, infertility, pressure symptoms, secondary anemia, etc. Treatment: (1) Expectant treatment or conservative treatment with Chinese medicine: that is, regular follow-up observation or treatment with Chinese medicine, and gynecological ultrasound once every 3-6 months; mainly suitable for asymptomatic fibroids, especially those with uterus size <10-12weeks of gestation, and for near-menopausal women, expecting the fibroids to shrink naturally after menopause; if excessive menstruation, pressure symptoms or fibroid enlargement especially at the rate of If symptoms of excessive menstruation, pressure or myoma enlargement especially at a faster rate appear during follow-up, surgical treatment will be used instead. (2) Drug therapy: mainly includes GnRHa, mifepristone, androgens, etc.; indications are: preoperative adjuvant therapy, patients with myomas near menopause, and patients with fibroids with serious comorbidities who cannot undergo surgery for the time being. Surgical treatment: myomectomy – only myomas are removed and the uterus is preserved; indications: age ≤ 40 years old, patients with fertility requirements or patients who do not have fertility requirements but do not want to remove the uterus and require preservation of the uterus. Hysterectomy (including total hysterectomy and subtotal hysterectomy) – suitable for patients without fertility requirements, uterus ≥ 12 weeks of gestation or fibroids ≥ 6 cm in diameter, excessive menstruation with hemorrhagic anemia, rapid growth of fibroids, symptoms of bladder or rectal compression, failure of conservative treatment or recurrence of fibroids after myomectomy.